Institute of Translational Health Sciences

转化健康科学研究所

基本信息

  • 批准号:
    10595094
  • 负责人:
  • 金额:
    $ 1051.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-01 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

The Institute of Translational Health Sciences (ITHS) has served as the clinical and translational science hub for Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) since 2007. The hub brings together 3 top US research institutions as partners: the University of Washington, Seattle Children’s, and the Fred Hutchinson Cancer Research Center. The spokes of the hub are academic, clinical, community-based, and other research organizations across the region. Leveraging networks and relationships built over several years, ITHS will continue to grow and strengthen our regional Collaboratory, a “center without walls”, to promote research that improves the health of the people across WWAMI and beyond. For Workforce Development, there is a strong need for clear career pathways, education, and environments that support professional growth for clinical and translational researchers (CTR) at all levels. ITHS will expand its competency-based TL1 predoctoral program in 2 ways: creation of a cohort at a WWAMI university and with a translational research curriculum to train health professional students during the course of their clinical training. The Institute will establish competency-based training and career advancement pathways for research staff. We will provide a learning system that can produce tailored educational content on-demand and at any time. To enhance Collaboration and Engagement, ITHS will enact team science as an operational standard in CTR, while cultivating a culture that rewards collaboration in faculty promotion. The Institute will integrate community stakeholders at all stages of translational research. We will develop a Rural Health Lab handing the leadership of a research project to a rural community with the aim to tackle a critical community health issue. Integrating Special Populations in research is a challenge. ITHS will promote the growth of a research workforce reflective of the communities served, through outreach, funding support, and training that embeds equity practices into research teams. We will incorporate programs to increase workforce diversity across the Institute. ITHS will reduce barriers to research participation through integration of remote technologies into clinical studies and develop best practices to ensure that “teleresearch” reduces rather than amplifies disparities. Methods and Processes are key to efficiency and quality in research. ITHS supported clinical trials offices have consolidated key functions under a single umbrella, providing opportunities to streamline research processes. We will support study metric tracking across a regional research network, enabling organizations to benchmark performance and collaboratively test and share process improvements. We will develop a pipeline of support for discovery research to ensure more health innovations reach the clinic. Informatics and “big data” drive future innovation. ITHS will make clinical data science more accessible, developing new methods, tools, and education for data exploration, machine learning, and real-world evidence analysis. We emphasize use of the electronic health record to implement evidence-based guidelines in the clinic.
转化健康科学研究所(InstituteofTranslationalHealthSciences,简称CIMIS)是临床和转化科学中心, 自2007年以来,华盛顿、怀俄明州、阿拉斯加、蒙大拿州和爱达荷州(WWAMI)。该中心汇集了美国三大 研究机构作为合作伙伴:华盛顿大学、西雅图儿童学院和弗雷德·哈钦森 癌症研究中心。该中心的辐条是学术、临床、社区和其他研究 整个地区的组织。利用多年来建立的网络和关系, 继续发展和加强我们的区域合作实验室,一个“没有围墙的中心”,以促进研究, 改善WWAMI及其他地区人民的健康。 对于劳动力发展,迫切需要明确的职业道路、教育和环境, 支持各级临床和转化研究人员(CTR)的专业发展。华为将扩大其 以能力为基础的TL1博士前课程有2种方式:在WWAMI大学创建一个队列,并与 转化研究课程,以培养卫生专业学生在他们的临床培训过程中。 研究所将为研究人员建立基于能力的培训和职业发展途径。我们 将提供一个学习系统,可以随时按需制作定制的教育内容。 为了加强协作和参与,CNAS将制定团队科学作为CTR的操作标准, 同时培养一种奖励教师晋升合作的文化。该研究所将整合社区 参与翻译研究各个阶段的利益相关者。我们将建立一个农村卫生实验室, 一个研究项目的一个农村社区,目的是解决一个关键的社区健康问题。 将特殊人群纳入研究是一项挑战。该计划将促进研究人员队伍的增长 通过外展、资金支持和嵌入公平的培训,反映所服务的社区 实践到研究团队。我们将纳入计划,以增加整个研究所的劳动力多样性。 通过将远程技术整合到临床研究中, 制定最佳做法,确保“远程研究”减少而不是扩大差距。 方法和过程是研究效率和质量的关键。美国临床试验协会支持的临床试验办公室 将关键职能整合到一个单一的总体框架下,为精简研究流程提供了机会。 我们将支持跨区域研究网络的研究指标跟踪,使组织能够进行基准测试 协作测试和共享流程改进。我们将建立一个支持渠道, 探索研究,以确保更多的健康创新到达诊所。 信息学和“大数据”驱动未来创新。CNAS将使临床数据科学更容易获得, 为数据探索、机器学习和真实世界的证据开发新的方法、工具和教育 分析.我们强调使用电子健康记录在诊所实施循证指南。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary L. Disis其他文献

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
  • DOI:
    10.1186/s40425-019-0640-y
  • 发表时间:
    2019-07-04
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Davide Bedognetti;Michele Ceccarelli;Lorenzo Galluzzi;Rongze Lu;Karolina Palucka;Josue Samayoa;Stefani Spranger;Sarah Warren;Kwok-Kin Wong;Elad Ziv;Diego Chowell;Lisa M. Coussens;Daniel D. De Carvalho;David G. DeNardo;Jérôme Galon;Howard L. Kaufman;Tomas Kirchhoff;Michael T. Lotze;Jason J. Luke;Andy J. Minn;Katerina Politi;Leonard D. Shultz;Richard Simon;Vésteinn Thórsson;Joanne B. Weidhaas;Maria Libera Ascierto;Paolo Antonio Ascierto;James M. Barnes;Valentin Barsan;Praveen K. Bommareddy;Adrian Bot;Sarah E. Church;Gennaro Ciliberto;Andrea De Maria;Dobrin Draganov;Winson S. Ho;Heather M. McGee;Anne Monette;Joseph F. Murphy;Paola Nisticò;Wungki Park;Maulik Patel;Michael Quigley;Laszlo Radvanyi;Harry Raftopoulos;Nils-Petter Rudqvist;Alexandra Snyder;Randy F. Sweis;Sara Valpione;Roberta Zappasodi;Lisa H. Butterfield;Mary L. Disis;Bernard A. Fox;Alessandra Cesano;Francesco M. Marincola
  • 通讯作者:
    Francesco M. Marincola
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
  • DOI:
    10.1007/s00262-010-0960-8
  • 发表时间:
    2011-01-08
  • 期刊:
  • 影响因子:
    5.100
  • 作者:
    Mary L. Disis
  • 通讯作者:
    Mary L. Disis
Tumor stromal barriers to the success of adoptive T cell therapy
  • DOI:
    10.1007/s00262-007-0356-6
  • 发表时间:
    2007-07-24
  • 期刊:
  • 影响因子:
    5.100
  • 作者:
    Vy Phan;Mary L. Disis
  • 通讯作者:
    Mary L. Disis
Vaccines for breast cancer prevention: Are we there yet?
预防乳腺癌的疫苗:我们还在吗?
  • DOI:
    10.1016/j.mam.2024.101292
  • 发表时间:
    2024-08-01
  • 期刊:
  • 影响因子:
    10.300
  • 作者:
    Shaveta Vinayak;Denise L. Cecil;Mary L. Disis
  • 通讯作者:
    Mary L. Disis
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
  • DOI:
    10.1186/s40425-018-0453-4
  • 发表时间:
    2018-12-01
  • 期刊:
  • 影响因子:
    10.600
  • 作者:
    Lisa H. Butterfield;Mary L. Disis;Bernard A. Fox;David R. Kaufman;Samir N. Khleif;Ena Wang
  • 通讯作者:
    Ena Wang

Mary L. Disis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary L. Disis', 18)}}的其他基金

Developing Community-Responsive mHealth and AI/ML: Understanding Perspectives of Hispanic Community Members in Washington State
开发社区响应型移动医疗和人工智能/机器学习:了解华盛顿州西班牙裔社区成员的观点
  • 批准号:
    10598360
  • 财政年份:
    2022
  • 资助金额:
    $ 1051.44万
  • 项目类别:
Institute of Translational Health Sciences
转化健康科学研究所
  • 批准号:
    10731707
  • 财政年份:
    2017
  • 资助金额:
    $ 1051.44万
  • 项目类别:
Institute of Translational Health Sciences
转化健康科学研究所
  • 批准号:
    10524284
  • 财政年份:
    2017
  • 资助金额:
    $ 1051.44万
  • 项目类别:
Institute of Translational Health Sciences
转化健康科学研究所
  • 批准号:
    10838269
  • 财政年份:
    2017
  • 资助金额:
    $ 1051.44万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8365202
  • 财政年份:
    2011
  • 资助金额:
    $ 1051.44万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC CLINICAL TRIALS
用于儿科临床试验的 CTSA 基础设施
  • 批准号:
    8365201
  • 财政年份:
    2011
  • 资助金额:
    $ 1051.44万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8365198
  • 财政年份:
    2011
  • 资助金额:
    $ 1051.44万
  • 项目类别:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
  • 批准号:
    8365200
  • 财政年份:
    2011
  • 资助金额:
    $ 1051.44万
  • 项目类别:
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse
接种 IGFBP-2 疫苗可预防卵巢癌复发
  • 批准号:
    8322539
  • 财政年份:
    2011
  • 资助金额:
    $ 1051.44万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
  • 批准号:
    8365199
  • 财政年份:
    2011
  • 资助金额:
    $ 1051.44万
  • 项目类别:

相似国自然基金

企业绩效评价的DEA-Benchmarking方法及动态博弈研究
  • 批准号:
    70571028
  • 批准年份:
    2005
  • 资助金额:
    16.5 万元
  • 项目类别:
    面上项目

相似海外基金

An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
  • 批准号:
    10100319
  • 财政年份:
    2024
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Collaborative R&D
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
  • 批准号:
    2796588
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Studentship
Collaborative Research: SHF: Medium: A Comprehensive Modeling Framework for Cross-Layer Benchmarking of In-Memory Computing Fabrics: From Devices to Applications
协作研究:SHF:Medium:内存计算结构跨层基准测试的综合建模框架:从设备到应用程序
  • 批准号:
    2347024
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Standard Grant
Elements: CausalBench: A Cyberinfrastructure for Causal-Learning Benchmarking for Efficacy, Reproducibility, and Scientific Collaboration
要素:CausalBench:用于因果学习基准测试的网络基础设施,以实现有效性、可重复性和科学协作
  • 批准号:
    2311716
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Standard Grant
Benchmarking collisional rates and hot electron transport in high-intensity laser-matter interaction
高强度激光-物质相互作用中碰撞率和热电子传输的基准测试
  • 批准号:
    2892813
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Studentship
FET: Medium: Quantum Algorithms, Complexity, Testing and Benchmarking
FET:中:量子算法、复杂性、测试和基准测试
  • 批准号:
    2311733
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Continuing Grant
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
  • 批准号:
    2233969
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Continuing Grant
Establishing and benchmarking advanced methods to comprehensively characterize somatic genome variation in single human cells
建立先进方法并对其进行基准测试,以全面表征单个人类细胞的体细胞基因组变异
  • 批准号:
    10662975
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
  • 批准号:
    2233968
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Continuing Grant
Benchmarking Quantum Advantage
量子优势基准测试
  • 批准号:
    EP/Y004418/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1051.44万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了